Table 4. Treatment and clinical outcomes of the COVID-19 patients.
Outcomes | All patients (n = 40) | Supplemental | P value | ||
---|---|---|---|---|---|
Oxygen not required (n = 34) | Oxygen required (n = 6) | ||||
Treatment | |||||
Antiviral therapya | 39 (98) | 33 (97) | 6 (100) | 1.000 | |
Antimalarial therapyb | 8 (20) | 2 (6) | 4 (67) | < 0.001 | |
CRRT | 1 (3) | 0 | 1 (17) | 0.150 | |
IMV | 1 (3) | 0 | 1 (17) | 0.150 | |
Clinical outcomes | |||||
Discharged | 39 (97) | 34 (100) | 5 (83) | 0.150 | |
Died | 1 (3) | 0 | 1 (17) | 0.150 | |
Readmission | 4 (10) | 4 (12) | 0 | 1.000 |
Data are presented as number (%).
COVID-19 = coronavirus disease 2019, CRRT = continuous renal replacement therapy, IMV = invasive mechanical ventilation.
aLopinavir/ritonavir, 400 mg/100 mg for 1 week; bHydroxychloroquine, 400 mg for 5 days.